What HCPs think about COVID-19’s impact on cancer
pharmaphorum
DECEMBER 9, 2020
Prominent industry figures, such as oncologist and ex-director of the WHO Cancer Programme Professor Karol Sikora, shared news articles and utilised their networks to raise awareness of decreased cancer diagnosis. During the COVID-19 pandemic, delayed or decreased cancer diagnosis was highlighted by HCPs as a key concern.
Let's personalize your content